Fresenius SE KGaAXSWX:FRE 71 PB Ratio is 1.12 as of Jun. 24, 2026, which is 13% below its 10-year median of 1.29. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 74.47% on this metric.
Fresenius SE & Co KGaA stock PB Ratio (=1.14) is close to 1-year low of 1.03.
The historical rank and industry rank for Fresenius SE KGaA's PB Ratio or its related term are showing as below:
XSWX:FRE'
s PB Ratio Range Over the Past 10 Years
Min: 0.53 Med: 1.29 Max: 3.51
Current: 1.14
During the past 13 years, Fresenius SE KGaA's highest PB Ratio was 3.51. The lowest was 0.53. And the median was 1.29.
XSWX:FRE's PB Ratio is ranked better than 74.47% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs XSWX:FRE: 1.14
During the past 12 months, Fresenius SE KGaA's average Book Value Per Share Growth Rate was 1.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Fresenius SE KGaA was 17.80% per year. The lowest was -27.90% per year. And the median was 9.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Fresenius SE KGaA PB Ratio Related Terms
Fresenius SE KGaA PB Ratio Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius SE KGaA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Fresenius SE KGaA (XSWX:FRE) has a PB Ratio of 1.12 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fresenius SE KGaA and its competitors. This is 13% below median its historical median of 1.29. Over the past decade, Fresenius SE KGaA's PB Ratio has ranged from 0.53 to 3.51. According to the industry distribution chart, Fresenius SE KGaA ranks #156 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 25.5%.
Is Fresenius SE KGaA's PB Ratio too high?
Fresenius SE KGaA's current PB Ratio of 1.12 is 13% below median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 3.51. The Healthcare Providers & Services industry median PB Ratio is 1.96. Fresenius SE KGaA's value of 1.12 is 42.9% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #156 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #156 out of 611 companies for PB Ratio. This puts Fresenius SE KGaA in the upper half of its industry. The industry median PB Ratio is 1.96. Fresenius SE KGaA's value of 1.12 is 42.9% below this benchmark. Historically, Fresenius SE KGaA's own PB Ratio has ranged from 0.53 to 3.51 over the past decade. While the company's 10-year median is 1.29 vs. the industry median of 1.96, Fresenius SE KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current PB Ratio of 1.12 is 42.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current PB Ratio is 1.12, which is 13% below median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current PB Ratio is 1.12, which is 13% below median its 10-year median of 1.29 and 42.9% below the Healthcare Providers & Services industry median of 1.96. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current PB Ratio is 1.12 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
PB Ratio: 1.12 (13% below median its 10-year median of 1.29)
GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
Industry Position: 42.9% below the Healthcare Providers & Services median (#156 of 611)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
